Streptococcal B vaccine - Emergent BioSolutionsAlternative Names: EBS-A42; EBS-C12; GBS vaccine - Emergent BioSolutions
Latest Information Update: 03 Mar 2014
At a glance
- Originator Emergent BioSolutions
- Class Streptococcal vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Streptococcal infections